Table 1.
Variable | Value |
---|---|
Age (yr) | 65.4 ± 15.4 (16–87) |
Sex | |
Women | 20 (83.3) |
Men | 4 (16.7) |
Body mass index (kg/m2) | 21.4 ± 2.7 |
Follow-up period (mo) | 59.9 ± 30.3 |
Duration of symptoms (mo) | 17.5 ± 23.4 |
Preoperative neurological status | |
With paralysis (MMT ≤ 3) | 8 (33.3) |
Without paralysis (MMT ≥ 4) | 16 (66.7) |
Tumor level | |
Cervical | 6 (25.0) |
Thoracic | 17 (70.8) |
Lumbar | 1 (4.2) |
Tumor length (mm) | 18.2 ± 5.2 |
Tumor occupation ratio (%) | 66.3 ± 14.5 |
Tumor localization | |
Dorsal | 8 (33.3) |
Lateral | 10 (41.7) |
Ventral | 5 (20.8) |
Unable to classify due to massive tumor size | 1 (4.2) |
Contrast MRI finding (n = 21) | |
Heterogeneous | 6 (28.6) |
Homogeneous | 15 (71.4) |
Calcification in CT scan (n = 23) | |
Positive | 15 (65.2) |
Negative | 8 (34.8) |
Maximum of Hounsfield unit value | 628.7 ± 423.4 |
Histological subtype (n = 22) | |
Meningothelial | 10 (45.5) |
Psammomatous | 6 (27.3) |
Transitional | 5 (22.7) |
Clear cell | 1 (4.5) |
Ki-67 index | 2.4 ± 1.9 |
Surgical procedure | |
Simpson grade 1 | 17 (70.8) |
Simpson grade 2 | 7 (29.2) |
Values are presented as mean±standard deviation (range) or number (%).
MMT, manual muscle testing; MRI, magnetic resonance imaging; CT, computed tomography.